Works matching Thomas Budd


Results: 64
    1
    2

    THOMAS BUDD.

    Published in:
    Notes & Queries, 1865, v. 7, n. 165, p. 168-d
    By:
    • T.
    Publication type:
    Article
    3

    THOMAS BUDD.

    Published in:
    Notes & Queries, 1864, v. 6, n. 151, p. 418-b
    By:
    • T.
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Association between biologically effective dose and local control after stereotactic body radiotherapy for metastatic sarcoma.

    Published in:
    Journal of Radiosurgery & SBRT, 2022, v. 8, n. 4, p. 265
    By:
    • Somasundaram, Eashwar;
    • Smile, Timothy D.;
    • Halima, Ahmed;
    • Broughman, James B.;
    • Reddy, Chandana A.;
    • Parsai, Shireen;
    • Scott, Jacob G.;
    • Shah, Chirag;
    • Chan, Timothy;
    • Campbell, Shauna;
    • Angelov, Lilyana;
    • Anderson, Peter M.;
    • Zahler, Stacy;
    • Trucco, Matteo;
    • Thomas, Stefanie M.;
    • Johnson, Shavaughn;
    • Mesko, Nathan;
    • Nystrom, Lukas;
    • Shepard, Dale;
    • Budd, George Thomas
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23

    Pelvic computed tomography of breast carcinoma patients.

    Published in:
    Cancer (0008543X), 1997, v. 79, n. 3, p. 500, doi. 10.1002/(SICI)1097-0142(19970201)79:3<500::AID-CNCR11>3.0.CO;2-7
    By:
    • Meyer, Jonathan I.;
    • Herts, Brian R.;
    • Einstein, David M.;
    • Singer, Anne A.;
    • Budd, G. Thomas;
    • Cohen, Mark A. H.
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33

    Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221).

    Published in:
    2018
    By:
    • Mongiovi, Jennifer M.;
    • Zirpoli, Gary R.;
    • Cannioto, Rikki;
    • Sucheston-Campbell, Lara E.;
    • Hershman, Dawn L.;
    • Unger, Joseph M.;
    • Moore, Halle C. F.;
    • Stewart, James A.;
    • Isaacs, Claudine;
    • Hobday, Timothy J.;
    • Salim, Muhammad;
    • Hortobagyi, Gabriel N.;
    • Gralow, Julie R.;
    • Thomas Budd, G.;
    • Albain, Kathy S.;
    • Ambrosone, Christine B.;
    • McCann, Susan E.
    Publication type:
    journal article
    34

    A Multimodal Approach to Discover Biomarkers for Taxane-Induced Peripheral Neuropathy (TIPN): A Study Protocol.

    Published in:
    Technology in Cancer Research & Treatment, 2022, v. 21, p. 1, doi. 10.1177/15330338221127169
    By:
    • Sharma, Anukriti;
    • Johnson, Ken B.;
    • Bie, Bihua;
    • Rhoades, Emily E.;
    • Sen, Alper;
    • Kida, Yuri;
    • Hockings, Jennifer;
    • Gatta, Alycia;
    • Davenport, Jacqueline;
    • Arcangelini, Connie;
    • Ritzu, Jennifer;
    • DeVecchio, Jennifer;
    • Hughen, Ron;
    • Wei, Mei;
    • Thomas Budd, G.;
    • Lynn Henry, N.;
    • Eng, Charis;
    • Foss, Joseph;
    • Rotroff, Daniel M.
    Publication type:
    Article
    35
    36
    37
    38

    High-dose cisplatin for metastatic soft tissue sarcoma.

    Published in:
    1990
    By:
    • Budd, G. Thomas;
    • Metch, Barbara;
    • Balcerzak, Stanley P.;
    • Fletcher, William S.;
    • Baker, Laurence H.;
    • Mortimer, Joanne E.;
    • Budd, G T;
    • Metch, B;
    • Balcerzak, S P;
    • Fletcher, W S;
    • Baker, L H;
    • Mortimer, J E
    Publication type:
    journal article
    39
    40

    The expression of TRMT2A, a novel cell cycleregulated protein, identifies a subset of breastcancer patients with HER2 over-expression thatare at an increased risk of recurrence.

    Published in:
    BMC Cancer, 2010, v. 10, p. 108, doi. 10.1186/1471-2407-10-108
    By:
    • Hicks, David G.;
    • Janarthanan, Bagi R.;
    • Vardarajan, Ramya;
    • Kulkarni, Swati A.;
    • Khoury, Thaer;
    • Dim, Daniel;
    • Budd, G. Thomas;
    • Yoder, Brian J.;
    • Tubbs, Raymond;
    • Schreeder, Marshall T.;
    • Estopinal, Noel C.;
    • Beck, Rodney A.;
    • Yanling Wang;
    • Ring, Brian Z.;
    • Seitz, Robert S.;
    • Ross, Douglas T.
    Publication type:
    Article
    41

    Expression of LC3B and FIP200/Atg17 in brain metastases of breast cancer.

    Published in:
    Journal of Neuro-Oncology, 2018, v. 140, n. 2, p. 237, doi. 10.1007/s11060-018-2959-5
    By:
    • Hashemi-Sadraei, Nooshin;
    • Müller-Greven, Gaëlle M.;
    • Abdul-Karim, Fadi W.;
    • Ulasov, Ilya;
    • Downs-Kelly, Erinn;
    • Burgett, Monica E.;
    • Lauko, Adam;
    • Qadan, Maha A.;
    • Weil, Robert J.;
    • Ahluwalia, Manmeet S.;
    • Du, Lingling;
    • Prayson, Richard A.;
    • Chao, Samuel T.;
    • Budd, Thomas G.;
    • Barnholtz-Sloan, Jill;
    • Nowacki, Amy S.;
    • Keri, Ruth A.;
    • Gladson, Candece L.
    Publication type:
    Article
    42

    Adherence to Cancer Prevention Lifestyle Recommendations Before, During, and 2 Years After Treatment for High-risk Breast Cancer.

    Published in:
    JAMA Network Open, 2023, v. 6, n. 5, p. e2311673, doi. 10.1001/jamanetworkopen.2023.11673
    By:
    • Cannioto, Rikki A.;
    • Attwood, Kristopher M.;
    • Davis, Evan W.;
    • Mendicino, Lucas A.;
    • Hutson, Alan;
    • Zirpoli, Gary R.;
    • Tang, Li;
    • Nair, Nisha M.;
    • Barlow, William;
    • Hershman, Dawn L.;
    • Unger, Joseph M.;
    • Moore, Halle C. F.;
    • Isaacs, Claudine;
    • Hobday, Timothy J.;
    • Hortobagyi, Gabriel N.;
    • Gralow, Julie R.;
    • Albain, Kathy S.;
    • Budd, G. Thomas;
    • Ambrosone, Christine B.
    Publication type:
    Article
    43

    Impact of early detection on cancer curability: A modified Delphi panel study.

    Published in:
    PLoS ONE, 2022, v. 17, n. 12, p. 1, doi. 10.1371/journal.pone.0279227
    By:
    • Schwartzberg, Lee;
    • Broder, Michael S.;
    • Ailawadhi, Sikander;
    • Beltran, Himisha;
    • Blakely, L. Johnetta;
    • Budd, G. Thomas;
    • Carr, Laurie;
    • Cecchini, Michael;
    • Cobb, Patrick;
    • Kansal, Anuraag;
    • Kim, Ashley;
    • Monk, Bradley J.;
    • Wong, Deborah J.;
    • Campos, Cynthia;
    • Yermilov, Irina
    Publication type:
    Article
    44
    45

    Phase II study of MEK inhibitor trametinib alone and in combination with AKT inhibitor GSK2141795/uprosertib in patients with metastatic triple negative breast cancer.

    Published in:
    Breast Cancer Research & Treatment, 2025, v. 210, n. 1, p. 179, doi. 10.1007/s10549-024-07551-z
    By:
    • Prasath, Vishnu;
    • Boutrid, Hinda;
    • Wesolowski, Robert;
    • Abdel-Rasoul, Mahmoud;
    • Timmers, Cynthia;
    • Lustberg, Maryam;
    • Layman, Rachel M.;
    • Macrae, Erin;
    • Mrozek, Ewa;
    • Shapiro, Charles;
    • Glover, Kristyn;
    • Vater, Mark;
    • Budd, G. Thomas;
    • Harris, Lyndsay;
    • Isaacs, Claudine;
    • Dees, Claire;
    • Perou, Charles M.;
    • Johnson, Gary L.;
    • Poklepovic, Andrew;
    • Chen, Helen
    Publication type:
    Article
    46

    Phase II study of MEK inhibitor trametinib alone and in combination with AKT inhibitor GSK2141795/uprosertib in patients with metastatic triple negative breast cancer.

    Published in:
    Breast Cancer Research & Treatment, 2025, v. 209, n. 3, p. 179, doi. 10.1007/s10549-024-07551-z
    By:
    • Prasath, Vishnu;
    • Boutrid, Hinda;
    • Wesolowski, Robert;
    • Abdel-Rasoul, Mahmoud;
    • Timmers, Cynthia;
    • Lustberg, Maryam;
    • Layman, Rachel M.;
    • Macrae, Erin;
    • Mrozek, Ewa;
    • Shapiro, Charles;
    • Glover, Kristyn;
    • Vater, Mark;
    • Budd, G. Thomas;
    • Harris, Lyndsay;
    • Isaacs, Claudine;
    • Dees, Claire;
    • Perou, Charles M.;
    • Johnson, Gary L.;
    • Poklepovic, Andrew;
    • Chen, Helen
    Publication type:
    Article
    47
    48
    49
    50